stockrowCardiol Therapeutics Inc. (CRDL) vs Organigram Global Inc. (OGI)
- Cardiol Therapeutics Inc. CRDL 0.98 +5.38%
- Organigram Global Inc. OGI 0.88 −5.38%
Cardiol Therapeutics Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $131.1M against $111.8M — 1.2× the size. Cardiol Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. has the higher net margin (28.4% vs 0.00%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 14 metrics below, Organigram Global Inc. leads on 8 and Cardiol Therapeutics Inc. on 6.
Valuation
Profitability
| Metric | CRDL | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 36.47% | 53.51% |
| Operating margin | 0.00% | (3.91%) | 0.00% |
| Net margin | 0.00% | 28.44% | (2.45%) |
| Free cash flow margin | 0.00% | (9.46%) | 0.00% |
| Return on equity | (171.13%) | 20.20% | (0.80%) |
| Return on assets | (124.40%) | 12.70% | (1.67%) |
| Return on invested capital | 0.00% | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack